Expression of concern

Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles

Paper Information

Record ID:
31328
Publication Date:
June 10, 2010
Retraction Date:
August 02, 2021 (4.3 years years ago)
Article Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Expression of concern Details

Nature of Retraction:

Expression of concern

Citations (293)

293
Total Citations
43
Post-Retraction
(14.7%)
246
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
12 Within 1 year
19 After 2+ years
1415 Days since retraction (latest)
Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: A review
Nicole Zoratto, Elita Montanari, Marco Viola et al. (7 authors)
Carbohydrate Polymers Open Access
Published: Apr 2021
23 citations
96 days before retraction
A Near-Infrared-II Polymer with Tandem Fluorophores Demonstrates Superior Biodegradability for Simultaneous Drug Tracking and Treatment Efficacy Feedback
Dengshuai Wei, Yingjie Yu, Yun Huang et al. (14 authors)
ACS Nano
Published: Mar 2021
93 citations
146 days before retraction
Active Targeting of Nanocarriers
Giovana R. Onzi, Sı́lvia Stanisçuaski Guterres, Adriana Raffin Pohlmann et al. (4 authors)
Springer eBooks
Published: Jan 2021
7 citations
213 days before retraction
Macrophage-targeted oligonucleotide therapeutics to downregulate inflammatory cytokines in non-alcoholic steatohepatitis
Kevin Craig
Unknown Journal Open Access
Published: Jan 2021
213 days before retraction
Nanotechnology advances in ovarian cancer
Kiranmayi Patnala, Rama Rao Malla, Soumya Vishwas
Elsevier eBooks
Published: Jan 2021
1 citation
213 days before retraction
Chitosan Nanoparticles: An Overview on Preparation, Characterization and Biomedical Applications
Arundathi Mesa, Grace Sugandha Sowjanya Mythatha, Rathna Silviya Lodi et al. (5 authors)
Environmental and microbial biotechnology
Published: Jan 2021
5 citations
213 days before retraction
Chitosan-based polyelectrolyte complexes in biomedical applications
Buddhadev Layek, Surajit Das, Shubhajit Paul
Elsevier eBooks
Published: Jan 2021
2 citations
213 days before retraction
Chitosan as a machine for biomolecule delivery: A review
Zohreh Mohammadi, Maryam Eini, Ali Rastegari et al. (4 authors)
Carbohydrate Polymers
Published: Nov 2020
67 citations
254 days before retraction
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Muhammad Imran Sajid, Muhammad Moazzam, Shun Kato et al. (5 authors)
Pharmaceuticals Open Access
Published: Oct 2020
197 citations
299 days before retraction
MST2 silencing induces apoptosis and inhibits tumor growth for estrogen receptor alpha-positive MCF-7 breast cancer
Joonwoo Park, Ga Hee Kim, Jeonggeun Lee et al. (10 authors)
Toxicology and Applied Pharmacology
Published: Sep 2020
15 citations
307 days before retraction
Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
Ujjwal Joshi, Nina Filipczak, Muhammad Muzamil Khan et al. (5 authors)
International Journal of Pharmaceutics
Published: Sep 2020
54 citations
312 days before retraction
Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials
Junwei Zhao, Federica Santino, Daria Giacomini et al. (4 authors)
Biomedicines Open Access
Published: Aug 2020
59 citations
342 days before retraction
pH‐Sensitive Modification of Chitosan as a Gene Carrier among Marine Biomaterials
Hu‐Lin Jiang, Lei Xing, Tian‐Jiao Zhou et al. (8 authors)
Encyclopedia of Marine Biotechnology
Published: Aug 2020
1 citation
356 days before retraction
iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment
Li Li, Mi Yang, Rutian Li et al. (6 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Jul 2020
8 citations
375 days before retraction
Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells
Huijie Yan, Yun You, Xinjian Li et al. (10 authors)
Frontiers in Pharmacology Open Access
Published: Jun 2020
66 citations
412 days before retraction
Study on the transfection efficiency of chitosan‐based gene vectors modified with poly‐l‐arginine peptides
Yan Zhang, Tianjiao Chu, Le Sun et al. (10 authors)
Journal of Biomedical Materials Research Part A
Published: May 2020
9 citations
455 days before retraction
Nanomedical Devices and Cancer Theranostics
Mohamed Moumaris, Jean-Michel Bretagne, N Abuaf
The Open Nanomedicine and Nanotechnology Journal Open Access
Published: Apr 2020
17 citations
468 days before retraction
RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer
Amit Singh Yadav, N. N. V. Radharani, Mahadeo Gorain et al. (8 authors)
Nanoscale
Published: Jan 2020
86 citations
579 days before retraction
Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells
Ujjwal Joshi
Unknown Journal Open Access
Published: Jan 2020
3 citations
579 days before retraction
Hitching a Ride: Enhancing Nucleic Acid Delivery into Target Cells Through Nanoparticles
Alekhya Penumarthi, Preetam Basak, Peter M. Smooker et al. (4 authors)
Environmental chemistry for a sustainable world
Published: Jan 2020
4 citations
579 days before retraction
Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects
Maryam Chamani, Parisa Maleki Dana, Shahla Chaichian et al. (5 authors)
IUBMB Life Open Access
Published: Dec 2019
3 citations
587 days before retraction
Recent progress in biomedical applications of RGD‐based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review
Mohsen Alipour, Marzieh Baneshi, Saman Hosseinkhani et al. (8 authors)
Journal of Biomedical Materials Research Part A
Published: Dec 2019
132 citations
592 days before retraction
Clinical and biological significance of <i>EZH2</i> expression in endometrial cancer
Ju‐Won Roh, Jung Eun Choi, Hee Dong Han et al. (13 authors)
Cancer Biology & Therapy Open Access
Published: Oct 2019
25 citations
650 days before retraction
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Byungji Kim, Ji‐Ho Park, Michael J. Sailor
Advanced Materials Open Access
Published: Sep 2019
253 citations
672 days before retraction
New Water-Soluble Oxyamino Chitosans as Biocompatible Vectors for Efficacious Anticancer Therapy via Co-Delivery of Gene and Drug
Mohini Kamra, Parikshit Moitra, Devasena Ponnalagu et al. (5 authors)
ACS Applied Materials & Interfaces Open Access
Published: Aug 2019
38 citations
711 days before retraction
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Shahin Aghamiri, Keyvan Fallah-Mehrjardi, Sasan Shabani et al. (6 authors)
Nanomedicine
Published: Aug 2019
34 citations
732 days before retraction
Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer
Mehdi Rajabi, Mary Adeyeye, Shaker A. Mousa
Current Medicinal Chemistry
Published: Jul 2019
14 citations
763 days before retraction
RNAi therapeutic and its innovative biotechnological evolution
Yuhua Weng, Haihua Xiao, Jinchao Zhang et al. (5 authors)
Biotechnology Advances
Published: Apr 2019
255 citations
829 days before retraction
Chitosan nanoparticles containing Physalis alkekengi-L extract: preparation, optimization and their antioxidant activity
Reza Mahmoudi, Maryam Tajali Ardakani, Behnam Hajipour‐Verdom et al. (10 authors)
Bulletin of Materials Science Open Access
Published: Apr 2019
36 citations
830 days before retraction
Characterizing a regulatory axis of microRNA-200b, the RNA-binding protein quaking, and cyclin D1 in modulating tumor angiogenesis and metastasis
Salma H. Azam
Unknown Journal
Published: Jan 2019
944 days before retraction
Small non-coding RNAs as a tool for personalized therapy in familial cancers
Saima Shakil Malik, Nosheen Masood, Alice Sherrard et al. (4 authors)
Elsevier eBooks
Published: Jan 2019
2 citations
944 days before retraction
Nanomaterials-Based siRNA Delivery: Routes of Administration, Hurdles and Role of Nanocarriers
Nitin Gupta, Divya Bharti, Ashok Kumar Jangid et al. (5 authors)
Springer eBooks
Published: Jan 2019
32 citations
944 days before retraction
Chitosan-based nanotherapeutics for ovarian cancer treatment
Leila Alizadeh, Amir Zarebkohan, Roya Salehi et al. (5 authors)
Journal of drug targeting
Published: Dec 2018
40 citations
945 days before retraction
Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action
Hari Sharan Adhikari, Paras Nath Yadav
International Journal of Biomaterials Open Access
Published: Dec 2018
308 citations
946 days before retraction
Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
A. C. Oliveira, Joana Fernandes, Anabela Gonçalves et al. (5 authors)
Current Drug Targets
Published: Nov 2018
22 citations
979 days before retraction
Hybrid Magnetic Nanostructures For Cancer Diagnosis And Therapy
Ioana Lavinia Ardelean, Denisa Ficai, Maria Sönmez et al. (8 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Nov 2018
7 citations
997 days before retraction
Enhancement of radiotherapeutic efficacy for esophageal cancer by paclitaxel-loaded red blood cell membrane nanoparticles modified by the recombinant protein anti-EGFR-iRGD
Wei Ren, Huizi Sha, Jing Yan et al. (10 authors)
Journal of Biomaterials Applications
Published: Nov 2018
15 citations
1005 days before retraction
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Yeongseon Byeon, Jeong‐Won Lee, Whan Soo Choi et al. (17 authors)
Cancer Research
Published: Aug 2018
116 citations
1082 days before retraction
Cancer hallmarks and malignancy features: Gateway for improved targeted drug delivery
Tiatou Souho, Lallepak Lamboni, Lin Xiao et al. (4 authors)
Biotechnology Advances
Published: Aug 2018
44 citations
1096 days before retraction
Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery
Xiaodong Xie, Yingying Zhang, Fengqiao Li et al. (8 authors)
Current Cancer Drug Targets
Published: Jun 2018
29 citations
1130 days before retraction
Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far
M. Y. Thanuja, C. Anupama, Sudhir H. Ranganath
Advanced Drug Delivery Reviews
Published: Jun 2018
135 citations
1138 days before retraction
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
Ludger Johannes, Marco Lucchino
Nucleic Acid Therapeutics Open Access
Published: Jun 2018
92 citations
1158 days before retraction
Recent preclinical and clinical advances in oligonucleotide conjugates
Kevin P. Craig, Marc Abrams, Mansoor M. Amiji
Expert Opinion on Drug Delivery
Published: May 2018
54 citations
1186 days before retraction
Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment
Emily B. Harrison, Salma H. Azam, Chad V. Pecot
Frontiers in Pharmacology Open Access
Published: Apr 2018
29 citations
1216 days before retraction
Cyclic RGD‐Coated Ultrasmall Gd<sub>2</sub>O<sub>3</sub> Nanoparticles as Tumor‐Targeting Positive Magnetic Resonance Imaging Contrast Agents
Mohammad Yaseen Ahmad, Md. Wasi Ahmad, Hyunsil Cha et al. (15 authors)
European Journal of Inorganic Chemistry
Published: Mar 2018
18 citations
1220 days before retraction
RGD peptide-based non-viral gene delivery vectors targeting integrin α<sub>v</sub>β<sub>3</sub>for cancer therapy
Shuang Fu, Xiaodong Xu, Yu Ma et al. (5 authors)
Journal of drug targeting
Published: Mar 2018
115 citations
1229 days before retraction
Antibacterial Coatings Based on Chitosan for Pharmaceutical and Biomedical Applications
Juliana Miguel Vaz, Daniele Pezzoli, Pascale Chevallier et al. (6 authors)
Current Pharmaceutical Design Open Access
Published: Feb 2018
58 citations
1259 days before retraction
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee Kim, Ji Eun Won, Yeongseon Byeon et al. (16 authors)
Drug Delivery Open Access
Published: Jan 2018
69 citations
1309 days before retraction
Small RNA-mediated prevention, diagnosis and therapies of cancer
Abdullah Al Hasan, A.T.M. Zafrul Azam
Elsevier eBooks
Published: Jan 2018
1 citation
1309 days before retraction
Atomic structural details of a protein grafted onto gold nanoparticles
Stefano Giuntini, Linda Cerofolini, Enrico Ravera et al. (5 authors)
Scientific Reports Open Access
Published: Dec 2017
24 citations
1327 days before retraction
Quick Stats
Total Citations: 293
Years Since Retraction: 4.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Prom…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 79 citations
CD44 Expression Denotes a Subpopulation of Gastric Cancer C…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 181 citations
Tumor Escape from Endogenous, Extracellular Matrix-Associat…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 164 citations
Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcin…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 96 citations
The Paradoxical Expression of Maspin in Ovarian Carcinoma
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 0 citations